Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors

The American Journal of Pathology
Chunyan HuP Jolicoeur

Abstract

The mouse mammary tumor virus (MMTV) provirus was found to target the Notch1 gene, producing insertional mutations in mammary tumors of MMTV/neu transgenic (Tg) mice. In these mammary tumors, the Notch1 gene is truncated upstream of the transmembrane domain, and the resulting Notch1 intracellular domain (Notch1(intra)), deleted of most extracellular sequences, is overexpressed. Although Notch1(intra) transforms mammary epithelial cells in vitro, its role in mammary gland tumor formation in vivo was not studied. Therefore, we generated MMTV/Notch1(intra) Tg mice that overexpress murine Notch1(intra) in the mammary glands. We observed that MMTV/Notch1(intra) Tg females were unable to feed their pups because of impaired ductal and lobulo-alveolar mammary gland development. This was associated with decreased proliferation of ductal and alveolar epithelial cells during rapid expansion at puberty and in early pregnancy, as well as decreased production of beta-casein. Notch1(intra) repressed expression of the beta-casein gene promoter, as assessed in vitro with a beta-casein/luciferase reporter construct. The MMTV/Notch1(intra) Tg females developed mammary gland tumors, confirming the oncogenic potential of Notch1(intra) in vivo. Furt...Continue Reading

References

Sep 15, 1995·Genes & Development·J P LydonB W O'Malley
Mar 1, 1995·Neuron·R I DorskyW A Harris
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·J W Pollard, L Hennighausen
May 1, 1993·The Journal of Cell Biology·R Kopan, H Weintraub
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·L A MilnerD I Martin
Jan 15, 1997·Genes & Development·X LiuL Hennighausen
Apr 7, 1998·Molecular and Cellular Biology·A BigasL A Milner
Jun 24, 1998·Genes & Development·I Greenwald
Apr 30, 1999·Science·S Artavanis-TsakonasR J Lake
Nov 11, 1999·Oncogene·A DiévartP Jolicoeur

❮ Previous
Next ❯

Citations

Apr 6, 2012·Breast Cancer Research and Treatment·Su-Hyeong KimShivendra V Singh
Sep 12, 2012·Breast Cancer Research and Treatment·Joomin LeeShivendra V Singh
Aug 19, 2008·Journal of Mammary Gland Biology and Neoplasia·Robert Callahan, Gilbert H Smith
Feb 26, 2009·Journal of Mammary Gland Biology and Neoplasia·David C Harmes, James DiRenzo
May 1, 2009·Journal of Mammary Gland Biology and Neoplasia·Derek C Radisky, Lynn C Hartmann
Feb 9, 2012·Current Treatment Options in Oncology·Tara BloomSteven T Rosen
Aug 31, 2007·Nature Clinical Practice. Oncology·Andrew H SimsRobert B Clarke
Feb 21, 2009·Human Molecular Genetics·Feyza EnginBrendan Lee
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Bart De StrooperMichael S Wolfe
Mar 8, 2012·Cancer Research·Xu ChenTian-Li Wang
Dec 7, 2007·The Journal of Clinical Investigation·Pasquale SansoneMassimiliano Bonafè
Jun 12, 2010·Blood·Maria R KamstrupRobert Gniadecki
Jun 16, 2011·Breast Cancer Research : BCR·Jianxun HanJoan Allalunis-Turner
Jun 18, 2011·Breast Cancer Research : BCR·Anthony G ClementzClodia Osipo
Sep 21, 2012·Breast Cancer Research : BCR·Matthew J SimmonsMichelle A Kelliher
Jul 6, 2013·Breast Cancer Research : BCR·Victoria BolósJosé Luis de la Pompa
Dec 21, 2013·Trends in Molecular Medicine·Fabienne Meier-Abt, Mohamed Bentires-Alj
Apr 9, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Gong-Ling PengChun-Ping Liu
Feb 12, 2014·Proceedings of the National Academy of Sciences of the United States of America·Maria E GonzalezCelina G Kleer
Mar 6, 2013·Pharmacology & Therapeutics·Ingrid Espinoza, Lucio Miele
Jul 21, 2014·Breast Cancer Research and Treatment·Anuradha SehrawatShivendra V Singh
Jul 9, 2014·Endocrine-related Cancer·Gerard A TarulliTheresa E Hickey
Sep 26, 2012·Cellular Oncology (Dordrecht)·Cigdem ErcanPaul J van Diest
Oct 15, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Huijie Gao, Chao Liu
May 24, 2013·Leukemia & Lymphoma·Maria Rørbæk KamstrupRobert Gniadecki
Feb 18, 2016·Stem Cells International·Ahmet AcarKeith Brennan
Aug 7, 2007·The American Journal of Pathology·Christine F O'NeillLucy Liaw
Nov 20, 2008·Cancer Science·Hideshi IshiiMasaki Mori
Apr 21, 2011·Journal of Cellular Physiology·Ahmed RaafatRobert Callahan
Apr 17, 2014·The Prostate·Filipe L F CarvalhoDavid M Berman
Apr 7, 2010·Biochemical Pharmacology·Ling YinZhao-Jun Liu
Dec 1, 2012·Biochimica Et Biophysica Acta·Christina Karamboulas, Laurie Ailles
Mar 4, 2014·Expert Opinion on Pharmacotherapy·Eilin AustreidHans Petter Eikesdal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis